If you're concerned about continuing treatment, your GP can explain the NHS prescribing guidelines, availability of alternatives, and any applicable prescription charges or exemptions
Controls received 0.23 mg/kg semaglutide with 0.5 mL DW
Insulin-like growth factor 1 and a cytosolic tyrosine kinase activate chloride outward transport during maturation of hippocampal neurons
Nutrition strategy Tirzepatide suppresses appetite significantly
The side effects are predominantly temporary, manageable with the right strategies, and do not outweigh the substantial benefits semaglutide offers for weight management and metabolic health
Tirzepatide, which combines the effects of glucose-dependent insulinotropic polypeptide and GLP-1, is undergoing phase 3 research for obesity treatment